LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $588 | +27.3% | 242 | 0.0% | 0.00% | – |
Q4 2022 | $462 | -53.8% | 242 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 242 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 242 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 242 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 242 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 242 | +70.4% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | +100.0% | 142 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | -33.3% | 142 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $3,000 | – | 142 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |